Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

No Thumbnail Available

Authors

Delmas, P. D.
Recker, R. R.
Chesnut, C. H.
Skag, A.
Stakkestad, J. A.
Emkey, R.
Gilbride, J.
Schimmer, R. C.
Christiansen, C.

Issue Date

2004

Volume

15

Issue

10

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Delmas, PD; Recker, RR; Chesnut, CH; Skag, A.; Stakkestad, JA; Emkey, R.; Gilbride, J.; Schimmer, RC; Christiansen, C. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporosis International. 2004, OCT. 15(10):792-798.

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

Identifier

ISSN

1433-2965
0937-941X

EISSN